|
|
|
Insider
Information: |
Gorman Kevin Charles |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
517,112 |
|
Indirect Shares
|
57,996 |
|
|
Direct
Value |
$71,519,380 |
|
|
Indirect Value
|
$8,086,382 |
|
|
Total
Shares |
575,108 |
|
|
Total
Value |
$79,605,763 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
17.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Chief Executive Office... |
2024-02-13 |
512,052 |
2004-09-22 |
57,996 |
Premium* |
|
Xencor Inc |
XNCR |
Director |
2024-02-13 |
5,060 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-02-06 |
4 |
AS |
$43.18 |
$129,972 |
D/D |
(3,010) |
250,542 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-04-12 |
4 |
AS |
$50.41 |
$988,085 |
D/D |
(19,596) |
332,607 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-05-02 |
4 |
AS |
$53.23 |
$1,157,167 |
D/D |
(21,739) |
332,607 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-01-16 |
4 |
AS |
$78.89 |
$295,820 |
D/D |
(3,750) |
336,357 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-02-05 |
4 |
AS |
$83.08 |
$498,164 |
D/D |
(5,983) |
342,874 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-02-06 |
4 |
AS |
$80.07 |
$8,006,620 |
D/D |
(100,000) |
342,874 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-05-01 |
4 |
AS |
$80.75 |
$10,241,735 |
D/D |
(126,832) |
347,033 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-02-04 |
4 |
AS |
$88.10 |
$275,321 |
D/D |
(3,125) |
408,082 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-02-05 |
4 |
AS |
$88.12 |
$395,895 |
D/D |
(4,489) |
413,943 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-02-06 |
4 |
AS |
$84.23 |
$344,986 |
D/D |
(4,096) |
417,597 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-06 |
4 |
AS |
$95.15 |
$4,844,380 |
D/D |
(50,911) |
417,597 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-07 |
4 |
AS |
$95.12 |
$262,440 |
D/D |
(2,759) |
417,597 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-08 |
4 |
AS |
$95.64 |
$2,518,154 |
D/D |
(26,330) |
417,597 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2020-02-05 |
4 |
AS |
$103.08 |
$561,726 |
D/D |
(5,449) |
425,529 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2020-02-06 |
4 |
AS |
$101.56 |
$441,068 |
D/D |
(4,343) |
429,436 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2020-02-07 |
4 |
AS |
$103.35 |
$335,696 |
D/D |
(3,248) |
432,357 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2020-04-24 |
4 |
AS |
$99.45 |
$289,016 |
D/D |
(2,906) |
434,971 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2020-08-05 |
4 |
AS |
$118.91 |
$403,101 |
D/D |
(3,390) |
438,021 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2020-11-12 |
4 |
AS |
$90.78 |
$307,748 |
D/D |
(3,390) |
441,071 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2021-01-08 |
4 |
AS |
$110.21 |
$33,973,877 |
D/D |
(308,250) |
441,071 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2021-02-05 |
4 |
AS |
$114.16 |
$276,504 |
D/D |
(2,422) |
443,249 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2021-02-08 |
4 |
AS |
$116.71 |
$1,221,864 |
D/D |
(10,466) |
452,972 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2022-02-07 |
4 |
AS |
$80.80 |
$703,907 |
D/D |
(8,710) |
460,801 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2022-02-08 |
4 |
AS |
$79.49 |
$180,768 |
D/D |
(2,274) |
462,844 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2023-01-31 |
4 |
AS |
$110.08 |
$297,997 |
D/D |
(2,707) |
465,278 |
0 |
% |
|
82 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|